AMRX · Amneal Pharmaceuticals, Inc. · Documents
$20.38
-0.10 (-0.49%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$6.51B
Shares
319.35M
Volume · Oct 23
4.93M
Avg daily vol (3M)
2.67M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| S-3ASR | — | 2026-09-03 | — | |
| 8-K | — | 2026-08-10 | — | |
| 10-Q | — | 2026-08-06 | 2026-06-30 | |
| 8-K | — | 2026-08-03 | — | |
| 8-K | — | 2026-07-31 | — | |
| DEFA14A | — | 2026-07-30 | — | |
| 8-K | — | 2026-07-30 | — | |
| DEFM14A | — | 2026-06-29 | — | |
| PREM14A | — | 2026-06-18 | — | |
| Investor Event Transcript | — | 2026-06-09 | 2026-06-30 | |
| 8-K | — | 2026-05-07 | — | |
| 10-Q | — | 2026-05-07 | 2026-03-31 | |
| 8-K | — | 2026-05-07 | 2026-05-06 | |
| DEFA14A | — | 2026-04-23 | — | |
| DEFA14A | — | 2026-04-22 | — | |
| DEFA14A | — | 2026-04-22 | — | |
| DEFA14A | — | 2026-04-22 | — | |
| DEFA14A | — | 2026-04-22 | — | |
| 8-K | — | 2026-04-22 | — | |
| DEFA14A | — | 2026-04-22 | — | |
| DEFA14A | — | 2026-04-22 | — | |
| DEF 14A | — | 2026-03-25 | 2026-05-06 | |
| DEFA14A | — | 2026-03-25 | — | |
| Investor Event Transcript | — | 2026-03-10 | 2026-03-31 | |
| 10-K | — | 2026-02-27 | 2025-12-31 | |
| 8-K | — | 2026-02-27 | — | |
| 8-K | — | 2026-02-03 | 2026-02-02 | |
| 8-K | — | 2026-01-28 | 2026-01-23 | |
| 8-K | — | 2026-01-13 | — | |
| 10-Q | — | 2025-11-06 | 2025-09-30 | |
| 8-K | — | 2025-10-30 | — | |
| 10-Q | — | 2025-08-07 | 2025-06-30 | |
| 8-K | — | 2025-08-05 | — | |
| 8-K/A | — | 2025-08-05 | — | |
| 8-K | — | 2025-08-01 | — | |
| 8-K | — | 2025-07-24 | — | |
| 8-K | — | 2025-07-21 | 2025-07-16 | |
| 8-K | — | 2025-07-21 | — | |
| 8-K | — | 2025-05-08 | — | |
| 10-Q | — | 2025-05-07 | 2025-03-31 | |
| 8-K | — | 2025-05-02 | — | |
| DEFA14A | — | 2025-03-25 | — | |
| DEF 14A | — | 2025-03-25 | 2025-05-06 | |
| 8-K | — | 2025-03-06 | 2025-03-01 | |
| 8-K | — | 2025-02-28 | — | |
| 10-K | — | 2025-02-28 | 2024-12-31 | |
| 8-K | — | 2025-01-15 | — | |
| 8-K/A | — | 2024-11-12 | 2024-11-08 | |
| 10-Q | — | 2024-11-12 | 2024-09-30 | |
| 8-K | — | 2024-11-08 | 2024-09-30 |
Showing 1–50 of 136 filings
Key facts
CIK
1723128
CUSIP
03168L105
13F (30d)
70 filings
66 filers
Visit website
Investor relations